Literature DB >> 23324914

[High-risk patients with aortic valve stenosis. Interventional therapy].

R Bekeredjian1, S T Pleger, E Chorianopoulos.   

Abstract

Aortic valve stenosis is the most prevalent, clinically significant valvular disorder in adult patients. Surgical valve replacement is the standard therapy for patients with symptomatic and severe aortic stenosis; however, many patients are suboptimal candidates for surgery due to age and co-morbidities. The development of transcatheter aortic valve implantation (TAVI) has broadened the therapeutic options, especially in high-risk patients. The first randomized study comparing surgical valve replacement with TAVI in operable high-risk patients show similar mortality and reduction in symptoms after a 2-year follow-up. These data support the use of this technique in high-risk patients with severe aortic stenosis.

Entities:  

Mesh:

Year:  2013        PMID: 23324914     DOI: 10.1007/s00059-012-3744-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  12 in total

1.  Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis.

Authors:  Corrado Tamburino; Marco Barbanti; Davide Capodanno; Carmelo Mignosa; Maurizio Gentile; Patrizia Aruta; Anna Maria Pistritto; Claudio Bonanno; Salvatore Bonura; Alessandra Cadoni; Simona Gulino; Maria Concetta Di Pasqua; Valeria Cammalleri; Marilena Scarabelli; Massimiliano Mulè; Sebastiano Immè; Giuliana Del Campo; Gian Paolo Ussia
Journal:  Am J Cardiol       Date:  2012-02-21       Impact factor: 2.778

2.  Two-year outcomes after transcatheter or surgical aortic-valve replacement.

Authors:  Susheel K Kodali; Mathew R Williams; Craig R Smith; Lars G Svensson; John G Webb; Raj R Makkar; Gregory P Fontana; Todd M Dewey; Vinod H Thourani; Augusto D Pichard; Michael Fischbein; Wilson Y Szeto; Scott Lim; Kevin L Greason; Paul S Teirstein; S Chris Malaisrie; Pamela S Douglas; Rebecca T Hahn; Brian Whisenant; Alan Zajarias; Duolao Wang; Jodi J Akin; William N Anderson; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

3.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

4.  Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age.

Authors:  Raffi Bekeredjian; Ulrike Krumsdorf; Emanuel Chorianopoulos; Klaus Kallenbach; Mathias Karck; Hugo Albert Katus; Wolfgang Rottbauer
Journal:  Am J Cardiol       Date:  2010-11-04       Impact factor: 2.778

5.  Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.

Authors:  Gian Paolo Ussia; Marco Barbanti; Anna Sonia Petronio; Giuseppe Tarantini; Federica Ettori; Antonio Colombo; Roberto Violini; Angelo Ramondo; Gennaro Santoro; Silvio Klugmann; Francesco Bedogni; Francesco Maisano; Antonio Marzocchi; Arnaldo Poli; Marco De Carlo; Massimo Napodano; Claudia Fiorina; Federico De Marco; David Antoniucci; Emanuela de Cillis; Davide Capodanno; Corrado Tamburino
Journal:  Eur Heart J       Date:  2012-01-12       Impact factor: 29.983

Review 6.  Aortic stenosis.

Authors:  J Ross; E Braunwald
Journal:  Circulation       Date:  1968-07       Impact factor: 29.690

7.  Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry.

Authors:  Danny Dvir; John Webb; Stephen Brecker; Sabine Bleiziffer; David Hildick-Smith; Antonio Colombo; Fleur Descoutures; Christian Hengstenberg; Neil E Moat; Raffi Bekeredjian; Massimo Napodano; Luca Testa; Thierry Lefevre; Victor Guetta; Henrik Nissen; José-María Hernández; David Roy; Rui C Teles; Amit Segev; Nicolas Dumonteil; Claudia Fiorina; Michael Gotzmann; Didier Tchetche; Mohamed Abdel-Wahab; Federico De Marco; Andreas Baumbach; Jean-Claude Laborde; Ran Kornowski
Journal:  Circulation       Date:  2012-10-10       Impact factor: 29.690

8.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?

Authors:  Bernard Iung; Agnès Cachier; Gabriel Baron; David Messika-Zeitoun; François Delahaye; Pilar Tornos; Christa Gohlke-Bärwolf; Eric Boersma; Philippe Ravaud; Alec Vahanian
Journal:  Eur Heart J       Date:  2005-09-01       Impact factor: 29.983

9.  Registry of transcatheter aortic-valve implantation in high-risk patients.

Authors:  Martine Gilard; Hélène Eltchaninoff; Bernard Iung; Patrick Donzeau-Gouge; Karine Chevreul; Jean Fajadet; Pascal Leprince; Alain Leguerrier; Michel Lievre; Alain Prat; Emmanuel Teiger; Thierry Lefevre; Dominique Himbert; Didier Tchetche; Didier Carrié; Bernard Albat; Alain Cribier; Gilles Rioufol; Arnaud Sudre; Didier Blanchard; Frederic Collet; Pierre Dos Santos; Nicolas Meneveau; Ashok Tirouvanziam; Christophe Caussin; Philippe Guyon; Jacques Boschat; Herve Le Breton; Frederic Collart; Remi Houel; Stephane Delpine; Geraud Souteyrand; Xavier Favereau; Patrick Ohlmann; Vincent Doisy; Gilles Grollier; Antoine Gommeaux; Jean-Philippe Claudel; Francois Bourlon; Bernard Bertrand; Eric Van Belle; Marc Laskar
Journal:  N Engl J Med       Date:  2012-05-03       Impact factor: 91.245

10.  Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry.

Authors:  Lutz Buellesfeld; Ulrich Gerckens; Raimund Erbel; Ralf Zahn; Axel Linke; Horst Sievert; Hans R Figulla; Karl-Heinz Kuck; Karl-Eugen Hauptmann; Rainer Hambrecht; Gert Richardt; Christoph Naber; Matthias Voehringer; Harald Mudra; Jochen Senges; Eberhard Grube
Journal:  J Invasive Cardiol       Date:  2012-10       Impact factor: 2.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.